United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$64Mraised across 2 rounds since 2025, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Jefferson Life Sciences and 1 other
Source recordedSEC filing: $30M sold, first sale Jun 2025
From Juvena Therapeutics's own website: 9 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
These 3 firms list Juvena Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Juvena Therapeutics's investors include Alumni Ventures, Felicis, Liquid 2 Ventures, Pathway Ventures and Creative Destruction Lab, and 4 more on record. Pathway Ventures led its latest round.
Juvena Therapeutics has raised $64M across 2 rounds since 2025.
Juvena Therapeutics's most recent round was a Series B of $34M in Jan 2026, led by Pathway Ventures.
Its most recent round, $34M in Jan 2026, is also its largest on record.
Juvena Therapeutics's first round on record, in Jul 2025, was backed by Alumni Ventures, Felicis and Liquid 2 Ventures and 2 others.
Juvena Therapeutics's latest named round is a Series B, in Jan 2026.
Juvena Therapeutics is based in the United States.
Pathway Ventures led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
